Valuation: Toho Holdings Co., Ltd.

Market Cap 265B 1.62B 1.42B 1.32B 1.22B 2.28B 156B 2.32B 15.61B 6.15B 76.66B 6.08B 5.95B P/E 2027 *
20.3x
P/E 2028 * 18.8x
Enterprise Value 265B 1.62B 1.42B 1.32B 1.22B 2.28B 156B 2.32B 15.61B 6.15B 76.66B 6.08B 5.95B EV / Sales 2027 *
0.17x
EV / Sales 2028 * 0.16x
Free-Float
76.61%
Yield 2027 *
4.39%
Yield 2028 * 3.96%
06-30 GNI Group Ltd. completed the acquisition of AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. CI
06-17 3D Investment Partners Pte. Ltd. Urges Shareholders of Toho Holdings Co., Ltd. CI
06-09 Toho Holdings Co., Ltd. Urging Shareholders to Vote Against Poison Pill Proposal CI
06-07 GNI to Acquire Ayumi Pharmaceutical in 44.8 Billion Yen Deal; Blackstone-Backed Fund Becomes Top Shareholder MT
06-04 GNI Group Ltd. agreed to acquire AYUMI Pharmaceutical Corporation from Blackstone Inc. (NYSE:BX), Toho Holdings Co., Ltd. and Hisamitsu Pharmaceutical Co., Inc. for ¥44.8 billion. CI
06-01 3D Investment Partners Urges Shareholders to Vote Against Toho HD?s Proposal 4 Poison Pill CI
05-13 Toho Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 CI
05-10 MP-2605 K.K. completed the acquisition of 53.42% stake in Solasto Corporation from Daito Trust Construction Co.,Ltd., Toho Holdings Co., Ltd., Goldman Sachs International, JPMorgan Securities Japan Co., Ltd., Medical Concierge Co., Ltd., The Master Trust Bank of Japan, Ltd., Custody Bank of Japan, Ltd. and others for ¥54.12 billion. CI
05-07 Japan's Listed Companies Face Investor Pressure on 20 Trillion Yen Real Estate Gains MT
04-30 Japan Shares Drop on Soft Output Data, Middle East Risks MT
04-29 Toho Holdings Flags Risks in 3D Investment Stake Build, Plans Vote on Proposed Acquisition MT
04-28 Toho Holdings Co., Ltd. Revises Year-End Dividend Guidance for the Fiscal Year Ended March 31, 2026 CI
04-28 Toho Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2026 CI
1 day+2.96%
1 week+0.84%
Current month+5.02%
1 month+5.37%
3 months-5.90%
6 months-15.30%
Current year-12.15%
1 week 3,915
Extreme 3915
4,125
1 month 3,786
Extreme 3786
4,148
Current year 3,729
Extreme 3729
5,031
1 year 3,729
Extreme 3729
5,726
3 years 2,681.5
Extreme 2681.5
5,726
5 years 1,678
Extreme 1678
5,726
10 years 1,653
Extreme 1653
5,726
Manager TitleAgeSince
Chief Executive Officer 74 2024-06-26
Director of Finance/CFO - -
Chief Operating Officer 61 2025-06-26
Director TitleAgeSince
Director/Board Member 60 2009-03-31
Director/Board Member 74 2015-05-31
Director/Board Member 61 2016-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.96%+0.84%-16.19%+48.24% 1.62B
+1.99%-0.06%+18.40%+103.52% 98.45B
+0.91%-0.21%+44.07%+145.06% 53.41B
-1.05%-3.07%-0.70%+250.62% 22.84B
-1.27%-1.38%-14.55%-19.35% 8.13B
-5.96%-5.05%-33.58%-35.62% 7.4B
-0.53%-4.15%-13.02%-29.09% 6.7B
-0.80%-1.73%+19.59%+28.57% 6.17B
-0.52%-2.75%-1.98%+21.60% 5.29B
-0.99%-1.96%-8.24%-9.25% 3.69B
Average -0.53%-2.72%-0.62%+50.43% 21.37B
Weighted average by Cap. +0.73%-1.38%+17.54%+109.41%

Financials

2027 *2028 *
Net sales 1,594B 9.72B 8.56B 7.95B 7.3B 13.7B 939B 13.94B 93.76B 36.96B 461B 36.53B 35.74B 1,630B 9.94B 8.75B 8.13B 7.47B 14.01B 960B 14.25B 95.87B 37.8B 471B 37.35B 36.55B
Net income 13.09B 79.85M 70.28M 65.31M 59.97M 113M 7.71B 114M 770M 304M 3.78B 300M 294M 14.28B 87.13M 76.69M 71.26M 65.43M 123M 8.42B 125M 840M 331M 4.13B 327M 320M
Net Debt - -
Logo Toho Holdings Co., Ltd.
Toho Holdings Co Ltd is a Japan-based company mainly engaged in the pharmaceutical wholesale business. The Company operates through five business segments. The Pharmaceutical Wholesale segment purchases pharmaceuticals and medical-related products from pharmaceutical manufacturers and sells them to hospitals, clinics and dispensing pharmacies. It is also engaged in the provision of data processing system and rental of real estate. The Dispensing Pharmacy segment is engaged in the management of insurance dispensing pharmacies and dispensing pharmacies. The Pharmaceutical Manufacture and Sale segment is engaged in the manufacture and sale of generic drugs and contract manufacturing of injectable drugs. The Clinical Trial Facility Support segment is engaged in the provision of support for clinical trial facilities. The Information Equipment Sales segment is engaged in the planning and sale of information processing equipment.
Employees
7,675
Date Price Change Volume
26-07-24 JP¥4,101.00 +2.96% 169,600
26-07-23 JP¥3,983.00 -0.99% 132,700
26-07-22 JP¥4,023.00 -0.30% 121,400
26-07-21 JP¥4,035.00 -0.79% 135,200
26-07-17 JP¥4,067.00 +1.12% 143,500
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
4,101.00JPY
Average target price
4,525.00JPY
Spread / Average Target
+10.34%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 8129 Stock